ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease (clinicaltrials.gov) - Oct 1, 2026 - P3 | N=600 | Not yet recruiting | Sponsor: Boehringer Ingelheim
New P3 trial • Genetic Disorders • Hepatology • Metabolic Disorders • Metabolic Dysfunction-Associated Steatotic Liver Disease • Obesity
|